Related Experiment Video

Updated: Aug 23, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic

Lyndon Chie1, Victor Adler, Fred K Friedman

  • 1Department of Pathology and Laboratory Medicine, New York Harbor VA Medical Center, Brooklyn, NY 11209, USA.

The Protein Journal
|June 18, 2004
PubMed

Insights

Oncogenic ras-p21 activates a specific pathway blocked by glutathione-S-transferase-pi (GST-pi). A GST-pi domain specifically inhibits oncogenic ras-p21, suggesting potential cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Oncogenic ras-p21 is a key driver in many human tumors.
  • Ras-p21 signaling pathways are crucial for cell growth and proliferation.
  • Jun-N-terminal kinase (JNK) and its substrate, jun, are involved in mitogenic signal transduction.

Purpose of the Study:

  • To investigate the role of glutathione-S-transferase-pi (GST-pi) in blocking oncogenic ras-p21 signaling.
  • To identify specific domains of GST-pi responsible for inhibiting JNK-jun activation.
  • To evaluate the potential of GST-pi as a targeted therapy for ras-induced tumors.

Main Methods:

  • Utilized a specific JNK-jun inhibitor, GST-pi, and its functional domains.
  • Assessed the effect of GST-pi domains on JNK-jun phosphorylation.
  • Examined the impact of a specific GST-pi domain (34-50) on oncogenic ras-p21-induced and insulin-induced oocyte maturation.

Main Results:

  • GST-pi effectively blocks the activation of JNK and jun by oncogenic ras-p21.
  • The 34-50 domain of GST-pi inhibits jun phosphorylation by JNK without affecting GST-pi binding.
  • This domain specifically blocks oncogenic ras-p21-induced oocyte maturation but not insulin-induced maturation.

Conclusions:

  • The 34-50 domain of GST-pi is a specific inhibitor of oncogenic ras-p21 signaling.
  • This domain's specificity suggests a potential therapeutic strategy for targeting ras-induced cancers.
  • Further research into GST-pi domains could lead to novel anti-cancer treatments.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...